Latest news
Phio Pharmaceuticals Corp. Q2 2026: Net income $(4.14)M, EPS $(0.36) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:36:00 GMTPhio Pharmaceuticals posts $4.1M Q2 net loss, cash $13.0M; advances PH-762 program - TradingViewTradingView · Thu, 06 Aug 2026 20:35:16 GMTPHIO: Q2 2026 net loss widened to $4.1M as PH-762 advanced, with $13M in cash and ongoing funding needs - TradingViewTradingView · Thu, 06 Aug 2026 20:18:30 GMTPhio intends to request an FDA meeting after 22-patient cancer study - Stock TitanStock Titan · Thu, 06 Aug 2026 20:05:00 GMTPhio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series - newsfilecorp.comnewsfilecorp.com · Tue, 28 Jul 2026 07:00:00 GMT